Overcoming Lack of Diversity in Cardiovascular Clinical Trials: A New Challenge and Strategies for Success

Rebecca F. Ortega, Clyde W. Yancy, Roxana Mehran, Wayne Batchelor*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)1690-1692
Number of pages3
JournalCirculation
DOIs
StateAccepted/In press - Jan 1 2020

Keywords

  • United States Food and Drug Administration
  • cardiovascular diseases
  • minority groups
  • standard of care
  • women

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this